BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38735973)

  • 1. High expression of SRSF1 facilitates osteosarcoma progression and unveils its potential mechanisms.
    Li S; Huang X; Zheng S; Zhang W; Liu F; Cao Q
    BMC Cancer; 2024 May; 24(1):580. PubMed ID: 38735973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines.
    Fenger JM; Roberts RD; Iwenofu OH; Bear MD; Zhang X; Couto JI; Modiano JF; Kisseberth WC; London CA
    BMC Cancer; 2016 Oct; 16(1):784. PubMed ID: 27724924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-624-5p promoted tumorigenesis and metastasis by suppressing hippo signaling through targeting PTPRB in osteosarcoma cells.
    Luo Y; Liu W; Tang P; Jiang D; Gu C; Huang Y; Gong F; Rong Y; Qian D; Chen J; Zhou Z; Zhao S; Wang J; Xu T; Wei Y; Yin G; Fan J; Cai W
    J Exp Clin Cancer Res; 2019 Dec; 38(1):488. PubMed ID: 31829261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zinc finger Asp-His-His-Cys palmitoyl -acyltransferase 19 accelerates tumor progression through wnt/β-catenin pathway and is upregulated by miR-940 in osteosarcoma.
    Liang S; Zhang X; Li J
    Bioengineered; 2022 Mar; 13(3):7367-7379. PubMed ID: 35297315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Splicing factor SRSF1 promotes breast cancer progression via oncogenic splice switching of PTPMT1.
    Du JX; Luo YH; Zhang SJ; Wang B; Chen C; Zhu GQ; Zhu P; Cai CZ; Wan JL; Cai JL; Chen SP; Dai Z; Zhu W
    J Exp Clin Cancer Res; 2021 May; 40(1):171. PubMed ID: 33992102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA binding protein serine/arginine splicing factor 1 promotes the proliferation, migration and invasion of hepatocellular carcinoma by interacting with RecQ protein-like 4 mRNA.
    Ye Y; Yu F; Li Z; Xie Y; Yu X
    Bioengineered; 2021 Dec; 12(1):6144-6154. PubMed ID: 34486474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. USP22 as a key regulator of glycolysis pathway in osteosarcoma: insights from bioinformatics and experimental approaches.
    Zhang Q; Zhu J; Xie J; Gu Y; Chen L
    PeerJ; 2024; 12():e17397. PubMed ID: 38784391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long Non-Coding RNA Urothelial Carcinoma Associated 1 Promotes Proliferation, Migration and Invasion of Osteosarcoma Cells by Regulating microRNA-182.
    Li Q; Xing W; Gong X; Wang Y
    Cell Physiol Biochem; 2018; 51(3):1149-1163. PubMed ID: 30481751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CircSMARCA5 Inhibits Migration of Glioblastoma Multiforme Cells by Regulating a Molecular Axis Involving Splicing Factors SRSF1/SRSF3/PTB.
    Barbagallo D; Caponnetto A; Cirnigliaro M; Brex D; Barbagallo C; D'Angeli F; Morrone A; Caltabiano R; Barbagallo GM; Ragusa M; Di Pietro C; Hansen TB; Purrello M
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29415469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-17 promotes osteosarcoma cells proliferation and migration and inhibits apoptosis by regulating SASH1 expression.
    Wu D; Zhang H; Ji F; Ding W
    Pathol Res Pract; 2019 Jan; 215(1):115-120. PubMed ID: 30396754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of MicroRNA-206 on Osteosarcoma Cell Proliferation, Apoptosis, Migration and Invasion by Targeting ANXA2 Through the AKT Signaling Pathway.
    Pan BL; Tong ZW; Wu L; Pan L; Li JE; Huang YG; Li SD; Du SX; Li XD
    Cell Physiol Biochem; 2018; 45(4):1410-1422. PubMed ID: 29462818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Exploration of Osteosarcoma Metastasis Diagnostic Markers Based on Tumor-Associated Neutrophils.
    Tan S; Chao R
    Discov Med; 2023 Jun; 35(176):300-311. PubMed ID: 37272097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MTHFD1L as a folate cycle enzyme correlates with prognostic outcome and its knockdown impairs cell invasive behaviors in osteosarcoma via mediating the AKT/mTOR pathway.
    Wang L; Yang Y; Wang XM; Wang CQ; Zhang YM; Li BL
    J Recept Signal Transduct Res; 2020 Dec; 40(6):584-590. PubMed ID: 32456526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circular RNA circ_UBAP2 facilitates the progression of osteosarcoma by regulating microRNA miR-637/high-mobility group box (HMGB) 2 axis.
    Ma W; Zhao X; Gao Y; Yao X; Zhang J; Xu Q
    Bioengineered; 2022 Feb; 13(2):4411-4427. PubMed ID: 35114890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non‑coding RNA GHET1 promotes osteosarcoma development and progression via Wnt/β‑catenin signaling pathway.
    Chen X; Zhao W; Fan W
    Oncol Rep; 2020 Jul; 44(1):349-359. PubMed ID: 32319657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA HOTTIP facilitates cell proliferation, invasion, and migration in osteosarcoma by interaction with PTBP1 to promote KHSRP level.
    Yao XY; Liu JF; Luo Y; Xu XZ; Bu J
    Cell Cycle; 2021 Feb; 20(3):283-297. PubMed ID: 33475442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing of long noncoding RNA SBF2-AS1 inhibits proliferation, migration and invasion and contributes to apoptosis in osteosarcoma cells by upregulating microRNA-30a to suppress FOXA1 expression.
    Dai JH; Huang WZ; Li C; Deng J; Lin SJ; Luo J
    Cell Cycle; 2019 Oct; 18(20):2727-2741. PubMed ID: 31432728
    [No Abstract]   [Full Text] [Related]  

  • 18. Long Noncoding RNA HCG9 Promotes Osteosarcoma Progression through RAD51 by Acting as a ceRNA of miR-34b-3p.
    Wang L; Li S; Qi L; Ling L
    Mediators Inflamm; 2021; 2021():9978882. PubMed ID: 34456631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA XIST promotes osteosarcoma progression by targeting YAP via miR-195-5p.
    Yang C; Wu K; Wang S; Wei G
    J Cell Biochem; 2018 Jul; 119(7):5646-5656. PubMed ID: 29384226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. circUBAP2 regulates osteosarcoma progression via the miR‑204‑3p/HMGA2 axis.
    Ma W; Xue N; Zhang J; Wang D; Yao X; Lin L; Xu Q
    Int J Oncol; 2021 Mar; 58(3):298-311. PubMed ID: 33650644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.